TW200512295A - Method for the gene transfer mediated by implused magnetic fields - Google Patents
Method for the gene transfer mediated by implused magnetic fieldsInfo
- Publication number
- TW200512295A TW200512295A TW092126270A TW92126270A TW200512295A TW 200512295 A TW200512295 A TW 200512295A TW 092126270 A TW092126270 A TW 092126270A TW 92126270 A TW92126270 A TW 92126270A TW 200512295 A TW200512295 A TW 200512295A
- Authority
- TW
- Taiwan
- Prior art keywords
- gene transfer
- cells
- gene
- dna
- nucleic acid
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A method is disclosed for transferring genetic materials like DNA into cells by applying a strong magnetic field in pulses. To mediate the gene transfer, cells and nucleic acid construct are mixed and exposed in pulsed magnetic field once or several times. Cells receiving the DNA in the cytoplasm and then nuclei, where the gene products encoded in DNA are expressed transiently or continuously. The nucleic acid construct can be either magnetic or non-magnetic. However, the use of superparamagnetic nanoparticles for the formation of nucleic acid construct, the efficiency of gene transfer can be promoted. The present invention discloses a simple and fast method for gene transfer to cells for the application in gene therapy, gene transfcetion, and drug delivery.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW092126270A TW200512295A (en) | 2003-09-23 | 2003-09-23 | Method for the gene transfer mediated by implused magnetic fields |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW092126270A TW200512295A (en) | 2003-09-23 | 2003-09-23 | Method for the gene transfer mediated by implused magnetic fields |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200512295A true TW200512295A (en) | 2005-04-01 |
Family
ID=57798605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW092126270A TW200512295A (en) | 2003-09-23 | 2003-09-23 | Method for the gene transfer mediated by implused magnetic fields |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW200512295A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11442117B2 (en) | 2016-11-09 | 2022-09-13 | Sigma Genetics, Inc. | Systems, devices, and methods for electroporation induced by magnetic fields |
-
2003
- 2003-09-23 TW TW092126270A patent/TW200512295A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11442117B2 (en) | 2016-11-09 | 2022-09-13 | Sigma Genetics, Inc. | Systems, devices, and methods for electroporation induced by magnetic fields |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | DNA nanostructure-based nucleic acid probes: construction and biological applications | |
US10597659B2 (en) | Multi-conjugate of SiRNA and preparing method thereof | |
Chang et al. | Micro-/nanoscale electroporation | |
Kim et al. | A multi-channel electroporation microchip for gene transfection in mammalian cells | |
Chakraborty et al. | A CRISPR/Cas9-based system for reprogramming cell lineage specification | |
Kocabey et al. | Cellular uptake of tile-assembled DNA nanotubes | |
JP2007514445A (en) | Delivery of DNA or RNA via gap junction from host cell to target cell, and cell-based delivery system for antisense or siRNA | |
AU4077100A (en) | Enhancement of the immune response for vaccine and gene therapy applications | |
AU2003234196A1 (en) | Functionalized nanoparticles and methods of use | |
Li et al. | Anti-CRISPR-based biosensors in the yeast S. cerevisiae | |
WO2003093469A3 (en) | Methods for delivering nucleic acid molecules into cells and assessment thereof | |
AU2003268654A1 (en) | Method of amplifying nucleic acid by electromagnetic induction heating and reaction container and reaction device to be used therein | |
Tian et al. | Nucleic acid–based aggregates and their biomedical applications | |
Huang et al. | High cell viability microfluidic electroporation in a curved channel | |
Qin et al. | F127/Calcium phosphate hybrid nanoparticles: a promising vector for improving siRNA delivery and gene silencing | |
Maucksch et al. | Transgene expression of transfected supercoiled plasmid DNA concatemers in mammalian cells | |
TW200512295A (en) | Method for the gene transfer mediated by implused magnetic fields | |
WO2003100060A3 (en) | Muc-1 antigen with reduced number of vntr repeat units | |
Siegler et al. | Efficient gene editing of CART cells with CRISPR-Cas12a for enhanced antitumor efficacy | |
Shanaa et al. | In Vivo Production of RNA Aptamers and Nanoparticles: Problems and Prospects | |
Alon et al. | Engineering a DNAzyme-based operon system for the production of DNA nanoscaffolds in living bacteria | |
EP4223881A1 (en) | Nucleic acid delivery method and system | |
He et al. | A novel gene carrier based on amino-modified silica nanoparticles | |
Liu et al. | Programmable technologies to manipulate gene expression at the RNA level | |
Novickij et al. | Different permeabilization patterns of splenocytes and thymocytes to combination of pulsed electric and magnetic field treatments |